ASLN logo

ASLN EBIT

Annual EBIT

-$39.76 M
+$7.86 M+16.50%

December 31, 2023

Summary

Performance

1-Year Change

+16.5%

3-Year Change

-152.86%

5-Year Change

+4.6%

15-Year Change

-0.72%

ASLN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.07 M

3-Year Low

-$47.62 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ASLN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ASLN next annual earnings announcement has not yet been scheduled

OtherASLNprofitabilitymetrics:

Annual Revenue

$12.00 M
ASLN annual revenue is $12.00 million

Annual Net Income

-$44.22 M
ASLN annual net profit is -$44.22 million

Annual EBITDA

-$39.41 M
ASLN annual EBITDA is -$39.41 million

Annual EPS

-$22.00
ASLN annual earnings per share is -$22.00

Quarterly EBIT

-$9.25 M
+$3.23 M+25.85%

March 31, 2024

Summary

Performance

3-Month Change

+25.85%

1-Year Change

+48.68%

3-Year Change

-76.43%

5-Year Change

-76.43%

ASLN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.38 M
ASLN quarterly earnings before interest & taxes is currently -272.15% below its historical high of $5.38 million

3-Year Low

-$18.03 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ASLN previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ASLN next earnings announcement has not yet been scheduled

OtherASLNprofitabilitymetrics:

Quarterly Revenue

-
ASLN quarterly revenue value is unknown

Quarterly Net Income

-$9.92 M
ASLN quarterly net profit is -$9.92 million

Quarterly EBITDA

-$9.25 M
ASLN quarterly EBITDA is -$9.25 million

Quarterly EPS

-$4.00
ASLN quarterly earnings per share is -$4.00

TTM EBIT

-$30.98 M
+$8.78 M+22.08%

March 31, 2024

Summary

Performance

3-Month Change

+22.08%

1-Year Change

+42.4%

3-Year Change

-48.36%

5-Year Change

-48.36%

ASLN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.63 M

3-Year Low

-$53.79 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ASLN previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ASLN next earnings announcement has not yet been scheduled

OtherASLNprofitabilitymetrics:

TTM Revenue

-
ASLN TTM revenue value is unknown

TTM Net Income

-$35.03 M
ASLN TTM net profit is -$35.03 million

TTM EBITDA

-$30.98 M
ASLN TTM EBITDA is -$30.98 million

TTM EPS

-$14.92
ASLN TTM earnings per share is -$14.92

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$39.76 M
ASLN annual earnings before interest & taxes is -$39.76 million

Annual Revenue

$12.00 M
ASLN annual revenue is $12.00 million

Annual Cost Of Goods Sold

-
ASLN annual cost of goods sold value is unknown

Annual Operating Expenses

$55.66 M
ASLN annual total operating expenses is $55.66 million

ASLN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.5%+48.7%+42.4%
3 y3 years-152.9%-76.4%-48.4%
5 y5 years+4.6%-76.4%-48.4%

ASLN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+33.7%+19.8%+1222.1%+94.9%+9.7%+73.6%
5 y5-year+152.9%+19.8%+1222.1%+216.6%+97.0%+73.6%
alltimeall time+462.5%+19.8%-272.1%+216.6%+1806.4%+73.6%

ASLAN Pharmaceuticals Limited EBIT History

DateAnnualQuarterlyTTM
Mar 2024
-
-$9.25 M(-25.9%)
-$30.98 M(-22.1%)
Dec 2023
-$39.76 M(-16.5%)
-$12.48 M(+46.0%)
-$39.76 M(-2.8%)
Sep 2023
-
-$8.55 M(+1121.6%)
-$40.91 M(-3.4%)
Jun 2023
-
-$699.90 K(-96.1%)
-$42.33 M(-21.3%)
Mar 2023
-
-$18.03 M(+32.3%)
-$53.79 M(+13.0%)
Dec 2022
-$47.62 M(+60.2%)
-$13.63 M(+36.7%)
-$47.62 M(+12.4%)
Sep 2022
-
-$9.97 M(-18.0%)
-$42.37 M(+4.7%)
Jun 2022
-
-$12.16 M(+2.6%)
-$40.46 M(+20.6%)
Mar 2022
-
-$11.85 M(+41.3%)
-$33.55 M(+18.7%)
Dec 2021
-$29.73 M(+89.1%)
-
-
Dec 2021
-
-$8.39 M(+4.1%)
-$28.25 M(+12.1%)
Sep 2021
-
-$8.06 M(+53.6%)
-$25.21 M(+20.7%)
Jun 2021
-
-$5.24 M(-20.0%)
-$20.88 M(+7.7%)
Mar 2021
-
-$6.56 M(+22.6%)
-$19.39 M(+23.3%)
Dec 2020
-$15.72 M(-65.6%)
-$5.35 M(+43.3%)
-$15.72 M(-60.4%)
Sep 2020
-
-$3.73 M(-0.5%)
-$39.68 M(-3.2%)
Jun 2020
-
-$3.75 M(+29.5%)
-$41.00 M(-7.9%)
Mar 2020
-
-$2.89 M(-90.1%)
-$44.51 M(-2.7%)
Dec 2019
-$45.76 M
-
-
Dec 2019
-
-$29.30 M(+479.2%)
-$45.76 M(+66.4%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$5.06 M(-30.3%)
-$27.49 M(-18.0%)
Jun 2019
-
-$7.26 M(+75.2%)
-$33.54 M(-9.9%)
Mar 2019
-
-$4.14 M(-62.5%)
-$37.20 M(-10.9%)
Dec 2018
-$41.68 M(+5.6%)
-
-
Dec 2018
-
-$11.03 M(-0.7%)
-$41.74 M(-7.5%)
Sep 2018
-
-$11.11 M(+1.7%)
-$45.13 M(+7.9%)
Jun 2018
-
-$10.92 M(+25.9%)
-$41.84 M(+4.6%)
Mar 2018
-
-$8.68 M(-39.8%)
-$40.01 M(+1.3%)
Dec 2017
-$39.48 M(+358.3%)
-
-
Dec 2017
-
-$14.43 M(+84.6%)
-$39.51 M(+24.0%)
Sep 2017
-
-$7.82 M(-14.1%)
-$31.85 M(+70.7%)
Jun 2017
-
-$9.09 M(+11.3%)
-$18.66 M(+46.2%)
Mar 2017
-
-$8.17 M(+20.7%)
-$12.76 M(+52.0%)
Dec 2016
-$8.61 M(-30.2%)
-
-
Dec 2016
-
-$6.77 M(-225.9%)
-$8.39 M(+416.5%)
Sep 2016
-
$5.38 M(-268.2%)
-$1.63 M(-76.8%)
Jun 2016
-
-$3.20 M(-16.0%)
-$7.00 M(+84.0%)
Mar 2016
-
-$3.80 M
-$3.80 M
Dec 2015
-$12.34 M(+74.5%)
-
-
Dec 2014
-$7.07 M
-
-

FAQ

  • What is ASLAN Pharmaceuticals Limited annual earnings before interest & taxes?
  • What is the all time high annual EBIT for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited annual EBIT year-on-year change?
  • What is ASLAN Pharmaceuticals Limited quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited quarterly EBIT year-on-year change?
  • What is ASLAN Pharmaceuticals Limited TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited TTM EBIT year-on-year change?

What is ASLAN Pharmaceuticals Limited annual earnings before interest & taxes?

The current annual EBIT of ASLN is -$39.76 M

What is the all time high annual EBIT for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high annual earnings before interest & taxes is -$7.07 M

What is ASLAN Pharmaceuticals Limited annual EBIT year-on-year change?

Over the past year, ASLN annual earnings before interest & taxes has changed by +$7.86 M (+16.50%)

What is ASLAN Pharmaceuticals Limited quarterly earnings before interest & taxes?

The current quarterly EBIT of ASLN is -$9.25 M

What is the all time high quarterly EBIT for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high quarterly earnings before interest & taxes is $5.38 M

What is ASLAN Pharmaceuticals Limited quarterly EBIT year-on-year change?

Over the past year, ASLN quarterly earnings before interest & taxes has changed by +$8.78 M (+48.68%)

What is ASLAN Pharmaceuticals Limited TTM earnings before interest & taxes?

The current TTM EBIT of ASLN is -$30.98 M

What is the all time high TTM EBIT for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high TTM earnings before interest & taxes is -$1.63 M

What is ASLAN Pharmaceuticals Limited TTM EBIT year-on-year change?

Over the past year, ASLN TTM earnings before interest & taxes has changed by +$22.81 M (+42.40%)